Cantor Fitzgerald Reaffirms Overweight Rating for I-Mab (NASDAQ:IMAB)

Cantor Fitzgerald restated their overweight rating on shares of I-Mab (NASDAQ:IMAB – Free Report) in a research report report published on Monday morning, PriceTargets.com reports. Cantor Fitzgerald also issued estimates for I-Mab’s FY2023 earnings at ($1.85) EPS and FY2024 earnings at ($1.14) EPS. Separately, Needham & Company LLC dropped their price target on shares of […]

Related Keywords

Hong Kong , ,Panagora Asset Management Inc ,Fund Management Hong Kong Co ,Nasdaq ,Cantor Fitzgerald ,Citigroup Inc ,Jpmorgan Chase Co ,Company Profile ,E Fund Management Hong Kong Co ,Needham Company ,Acadian Asset Management ,Free Report ,Fund Management Hong Kong ,Asset Management ,Panagora Asset Management ,Get Free Report ,I Mab Daily ,I Mab ,Nasdaq Imab ,Himab ,Medical ,Reiterated Rating ,